Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ev3's Axium gains CE mark:

This article was originally published in Clinica

Executive Summary

Plymouth, Minnesota-based ev3 has CE-marked for sale in Europe its Axium detachable coil system for the endovascular embolisation of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The device is also indicated for use in the treatment of peripheral vascular abnormalities. It is estimated that around one in 15 people in the US will develop a cerebral aneurysm during their lifetime, said the firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel